|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 301-325 out of 1201. << < 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 > >>
Public Release: 11-Apr-2013
Report finds continuing challenges in changing behaviors that increase cancer risk An annual report from the American Cancer Society finds continuing challenges in changing behaviors and risk factors in order to reduce suffering and death from cancer. 
American Cancer Society
Contact: David Sampson
Public Release: 11-Apr-2013
 NatureScientists map elusive 3-D structure of telomerase enzyme, key actor in cancer, aging Like finally seeing the gears of a watch and how they work together, all components of an entire telomerase enzyme complex have been positioned into a three-dimensional structure for the first time. This first complete visual map of the telomerase enzyme complex, known to play a significant role in cancer and aging, is a breakthrough from UCLA and UC Berkeley biochemists. Contact: Stuart Wolpert
Public Release: 11-Apr-2013
Journal of Biological ChemistryLSUHSC research discovers new drug target for metastatic breast cancer Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
National Institutes of Health, Susan Komen Foundation, Louisiana Cancer Research Center
Contact: Leslie Capo
Public Release: 11-Apr-2013
Acta Obstetricia et Gynecologica ScandinavicaEndometriosis treatments lower ovarian cancer risk A novel study shows women who undergo surgical treatment for endometriosis have a lower risk of developing ovarian cancer. According to results published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, hormonal treatments for endometriosis did not lower ovarian cancer risk. Contact: Dawn Peters
Public Release: 11-Apr-2013
AACR Annual Meeting 2013Soy-based compound may reduce tumor cell proliferation in colorectal cancer Research on a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate cancer was presented at the American Association for Cancer Research 2013 Annual Meeting. The meeting took place April 6-10, 2013, in Washington, DC. Contact: Mount Sinai Press Office
Public Release: 11-Apr-2013
Proceedings of the National Academy of SciencesA novel surface marker helps scientists 'fish out' mammary gland stem cells In an advancement by the Hannon lab at CSHL, it is now possible to profile normal and cancerous mammary stem cells at an unprecedented high degree of purity. This may help identify genes that should be investigated as the next breast cancer drug targets.
National Institutes of Health
Contact: Peter Tarr
Public Release: 10-Apr-2013
Science Translational MedicineSignature of circulating breast tumor cells that spread to the brain found Some breast tumor circulating cells in the bloodstream are marked by a constellation of biomarkers that identify them as those destined to seed the brain with a deadly spread of cancer, said researchers led by those at Baylor College of Medicine in a report that appears online in the journal Science Translational Medicine. Contact: Glenna Picton
Public Release: 10-Apr-2013
American Chemical Society's 245th National Meeting & ExpositionGUMBOS technology promises new drugs, electronic devices Mention a breakthrough involving "gumbo" technology, and people think of a new twist on the local dish, the stew that's the quintessence of southern Louisiana cooking. But scientific presentations at a meeting of the world's largest scientific society are focusing on what may be an advance in developing GUMBOS-based materials with far-reaching medical, electronic and other uses. Scientists reported on the materials at the 245th National Meeting & Exposition of the American Chemical Society. Contact: Michael Bernstein
Public Release: 10-Apr-2013
AACR Annual Meeting 2013Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American Association of Cancer Research Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy. Contact: Rachel Steinhardt
Public Release: 10-Apr-2013
AACR Annual Meeting 2013Fox Chase researchers find some lung cancers linked to common virus A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April 10. Contact: Diana Quattrone
Public Release: 10-Apr-2013
AACR Annual Meeting 2013AACR news: Studies show increasing evidence that androgen drives breast cancer Estrogen and progesterone receptors, and the gene HER2 -- these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: Androgen receptors. Contact: Garth Sundem
Public Release: 10-Apr-2013
Journal of Biological ChemistryALBA Synchrotron used for first time as a microscope to determine protein structure A study led by the Universitat Autònoma de Barcelona has determined the three-dimensional structure of certain proteins linked to the correct functioning of the cell division process: The LC8 and Nek9 pair. This study, published in the Journal of Biological Chemistry, could have implications for research into diseases related to this process, such as cancer. Contact: Octavi López Coronado
Public Release: 10-Apr-2013
Journal of Biological ChemistryLSUHSC research reveals Rx target for HPV, Hep C and related cancers New discoveries by a team of scientists at LSU Health Sciences Center New Orleans for the first time reveal the inner workings of a master regulator that controls functions as diverse as the ability of nerve cells to "rewire" themselves in response to external stimuli and the mechanism by which certain viruses hijack normal cellular processes to facilitate their replication that can ultimately lead to cancer.
National Institutes of Health
Contact: Leslie Capo
Public Release: 10-Apr-2013
Molecular Cancer TherapeuticsNaturally-occurring substance proves effective against deadly skin cancer in laboratory tests For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of deaths from skin cancer.
Texas Biomedical Forum, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Contact: Joseph Carey
Public Release: 10-Apr-2013
The Open Virology JournalSome types of papilloma virus might prevent cervical cancer Certain types of papilloma virus might actually prevent cervical cancer, according to a new study by researchers from The University of Manchester.
Humane Research Trust
Contact: Alison Barbuti
Public Release: 10-Apr-2013
Proceedings of the National Academy of SciencesUNC researchers engineer 'protein switch' to dissect role of cancer's key players Researchers at the University of North Carolina at Chapel Hill School of Medicine have "rationally rewired" some of the cell's smallest components to create proteins that can be switched on or off by command. These "protein switches" can be used to interrogate the inner workings of each cell, helping scientists uncover the molecular mechanisms of human health and disease.
NIH/National Cancer Institute, National Institutes of Health, NIH/National Institute of Environmental Health Sciences
Contact: Les Lang
Public Release: 9-Apr-2013
AACR Annual Meeting 2013TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute. Early results from the phase I, first in-human study of an RNA interface drug were announced during the American Association for Cancer Research Annual Meeting 2013. Contact: Steve Yozwiak
Public Release: 9-Apr-2013
AACR Annual Meeting 2013TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013 The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute and Scottsdale Healthcare, and presented today at the American Association for Cancer Research Annual Meeting 2013. Contact: Steve Yozwiak
Public Release: 9-Apr-2013
AACR Annual Meeting 2013AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize In results presented at the AACR Annual Meeting 2013, researchers from the University of Colorado Cancer Center show that the Six2 homeoprotein, while not involved in primary tumor growth, allows cells to detach from substrates and to survive their transition through the bloodstream to faraway sites of metastasis. Contact: Garth Sundem
Public Release: 9-Apr-2013
Journal of Clinical OncologyFirst genetic factor in prostate cancer prognosis identified Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. Contact: Nuria Noriega
Public Release: 9-Apr-2013
New PhytologistReliably higher levels of healthy compound in Beneforte broccoli Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound. Broccoli contains a compound called glucoraphanin, which has been shown to promote health by maintaining cardiovascular health and a reduction in the risk of cancer. A long term breeding programme to increase glucoraphanin levels has resulted in the commercial release of Beneforte broccoli. Beneforte was developed by crossing standard broccoli with a wild relative.
Biological Sciences Research Council
Contact: Andrew Chapple
Public Release: 9-Apr-2013
PLOS ONE2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study shows Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have found that when given together, a two-drug combination acts synergistically in test animals modeled with sarcoma tumors. They report that the drug combination of MK-1775 and gemcitabine resulted in a 70 percent decrease in the tumor volume when compared to receiving one drug or the other. Contact: Kim Polacek
Public Release: 9-Apr-2013
AACR Annual Meeting 2013UCLA researchers find potential link between auto pollution, some childhood cancers Researchers at UCLA's Fielding School of Public Health, led by Julia Heck, assistant researcher in the department of epidemiology and member of the Jonsson Comprehensive Cancer Center, have found a possible link between exposure to traffic-related air pollution and several childhood cancers in the first study on traffic air pollution and childhood cancers (other than leukemia, lymphomas and brain tumors). Contact: Shaun Mason
Public Release: 9-Apr-2013
AACR Annual Meeting 2013AACR: Positive data supports advancing BIND-014 to phase 2 clinical trials for solid tumors BIND Therapeutics clinical investigators presented Phase 1 results with BIND-014, its targeted docetaxel Accurin, in 28 heavily-pretreated patients with advanced or metastatic solid tumors. BIND-014 was shown to be generally safe and well-tolerated at the established maximum tolerated dose and showed encouraging signs of anti-tumor activity including one complete response, three partial responses and five patients with stable disease lasting at least four cycles.
BIND Therapeutics
Contact: Kathryn Morris
Public Release: 9-Apr-2013
Breast Cancer Research and Treatment25 percent don't complete recommended breast cancer treatment One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.
NIH/National Cancer Institute, NIH/National Institute for Nursing Research, American Cancer Society
Contact: Nicole Fawcett
Showing releases 301-325 out of 1201. << < 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|